Key statistics
On Friday, Hercules Capital Inc (HTGC:NYQ) closed at 14.21, 0.78% above its 52-week low of 14.10, set on Feb 27, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 15.25 |
|---|---|
| High | 15.29 |
| Low | 14.10 |
| Bid | 14.33 |
| Offer | 14.52 |
| Previous close | 15.43 |
| Average volume | 5.34m |
|---|---|
| Shares outstanding | 183.70m |
| Free float | 179.94m |
| P/E (TTM) | 7.76 |
| Market cap | 2.61bn USD |
| EPS (TTM) | 1.83 USD |
| Annual div (ADY) | 1.88 USD |
|---|---|
| Annual div yield (ADY) | 13.23% |
| Div ex-date | Feb 25 2026 |
| Div pay-date | Mar 04 2026 |
Data delayed at least 15 minutes, as of Feb 27 2026 21:00 GMT.
More ▼
- Hercules Capital Reports Fourth Quarter and Full-Year 2025 Financial Results
- Hercules Capital Closes Institutional Notes Offering of $300.0 Million 5.350% Unsecured Notes due 2029
- Hercules Capital Announces New Supplemental Cash Distribution of $0.28 per Share
- Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Fourth Quarter 2025
- Hercules Capital Prices Institutional Notes Offering of $300.0 Million 5.350% Notes due 2029
- Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2025 Financial Results and Conference Call
- Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI*
- enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
- Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD
More ▼
